Skip to main content

Table 1 Experimental protocol and basic characteristics in AICH patients (n = 8) and healthy controls (n = 4) group

From: Identification of novel biomarker and therapeutic target candidates for acute intracerebral hemorrhage by quantitative plasma proteomics

Block

Tissue

Disease or normal

Patient number

Age/gender

District and hospital

TMT labeling reagent ID

TMT labeling code

1

1

Normal

1

66/F

Nanjing

1

126

1

2

AICH

2

61/F

Nanjing

1

127

1

4

AICH

3

65/F

Nanjing

1

129

  

Reference

   

1

131

2

6

Normal

4

60/M

Nanjing

2

126

2

7

AICH

5

56/M

Nanjing

2

127

2

9

AICH

6

58/M

Nanjing

2

129

  

Reference

   

2

131

3

11

Normal

7

71/M

Zhenjiang

3

126

3

12

AICH

8

69/M

Zhenjiang

3

127

3

14

AICH

9

66/M

Zhenjiang

3

129

  

Reference

   

3

131

4

16

Normal

10

56/F

Zhenjiang

4

126

4

17

AICH

11

61/F

Zhenjiang

4

127

4

19

AICH

12

57/F

Zhenjiang

4

129

  

Reference

   

4

131

  1. Reference represents a reference sample, i.e., a mixed sample of all plasma samples by internal standard method
  2. AICH acute intracerebral hemorrhage, F female, M male
Back to article page

Clinical Proteomics

ISSN: 1559-0275